Assessment of Arrhythmic BuRdEn With Post-ProCedural COntinuous ElectRocarDiographic Monitoring in Patients Undergoing Transcatheter Aortic Valve Implantation: The RECORD Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 28, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2025

Conditions
TAVIECG Monitoring
Interventions
DEVICE

Cardiostat

This is a prospective observational study including patients accepted by the heart team for a TAVI procedure. There will be no restriction regarding the type of valve and approach used for the TAVI procedure. Following the TAVI procedure, the patients will be under telemetry until hospital discharge and, at hospital discharge, they will be monitorized up to 4 more weeks using the CardioSTAT® device.

Trial Locations (1)

G1V 4G5

IUCPQ, Québec

All Listed Sponsors
lead

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

OTHER

NCT04298593 - Assessment of Arrhythmic BuRdEn With Post-ProCedural COntinuous ElectRocarDiographic Monitoring in Patients Undergoing Transcatheter Aortic Valve Implantation: The RECORD Study | Biotech Hunter | Biotech Hunter